Antibiotice S.A. (BVB:ATB)

Market Cap	1.40B
Revenue (ttm)	686.57M
Net Income (ttm)	99.42M
Shares Out	671.34M
EPS (ttm)	0.15
PE Ratio	14.08
Forward PE	n/a
Dividend	0.08 (3.98%)
Ex-Dividend Date	Sep 25, 2025

Volume	24,128
Average Volume	242,278
Open	2.090
Previous Close	n/a
Day's Range	2.065 - 2.105
52-Week Range	1.870 - 3.440
Beta	0.11
RSI	35.81
Earnings Date	Apr 10, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; and veterinary medicines. Its products are av...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,350
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2024, Antibiotice's revenue was 686.57 million, an increase of 11.58% compared to the previous year's 615.29 million. Earnings were 99.42 million, an increase of 22.60%.